tirzepatide in egypt MOUNJARO 10 MG / 0.5 ML ( ) FOR SUBCUTANEOUS INJECTION 4 PRE-FILLED PENS egypt #mounjaro #mounjaro #evapharma #obesity

In the prospective cohort study published by Navodnik et al

10/02/24: Tirzepatide No Longer on FDAs Drug Shortage List 12/20/24: FDA Removes Semaglutide from Drug Shortage List 02/18/25: FDA states pharmacies must discontinue compounding, distributing and dispensing tirzepatide 02/24/25: FDA Confirms End of Tirzepatide Drug Shortage 03/05/25: U.S

Clinical observations show meaningful reductions in body weight among users

Iamsumang, W., Leerunyakul, K., & Suchonwanit, P

Originally developed for type II diabetes, it is now widely used to help patients lose weight when combined with diet and exercise

The REVOLUTION study